Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

I just don't understand the salary reductions that Pykett and crew had to endure for 2014. I say their pay should all be doubled now and their bonuses should all be tripled and the sooner the better. They have succeeded in destroying the share price since September 2013. Imagine the impact of a CRL in June or October. I don't want or expect any CRL's but with the new trend of doing everything they can to harm the shareholder, two CRL's from the FDA this year and a complete denial from the EU will not shock me one bit. Nor will the shorts refusing to cover in the event of these three potential failures surprise me. They seem to be waiting for the day when NAVB trades at BID .008 X .009. If the current stagnancy and management INATTENTION to shareholders continues, the shorts may not have to wait much longer for the sub-penny level.

How about another Crede deal to the rescue next week. Instead of trading sub-penny too soon, we can at least get the sub-dollar trading underway. Crede shall pay $0.95 "per unit" this time and will receive 80,000,000 shares of common stock and 175,000,000 warrants with a strike price of 1.30. Brent Larson can hype up how great this deal is for the stock and company. Meanwhile, the stock trades at .50 and there is still no short covering.

This is all starting to look like one of the best orchestrated stock scams in recent years. The Crede deal destroyed the share price and PM and the shorts are taking the destruction further. Meanwhile, Pykett, Tulip, and Larson mock and disrespect shareholders. Wonderful.